documents: FDA-2007-A-0099-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-A-0099-0005 FDA FDA-2007-A-0099 Response Letter from FDA CDER to GlaxoSmithKline, Wilmer Cutler Pickering Hale and Dorr LLP, Ropes & Gray LLP, Novo Nordisk Inc. and Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Other Response(s) 2020-06-01T04:00:00Z 2020 6 2020-06-01T04:00:00Z   2020-06-02T02:12:05Z   0 0 09000064846c252f

Links from other tables